Our hope is that our trial results turn up the volume on the debate around breast cancer prevention, says Paul Goss of the Massachusetts General Hospital Cancer Center in Boston, head of the research team
digoxin and lasix Department of Haematology, Azienda Policlinico Vittorio Emanuele Catania, Italy
